Skip to content

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery

Atrial Fibrillation | Stroke

Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient perioperative atrial fibrillation after noncardiac surgery and additional stroke risk factors.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    55 and up

Participation Criteria

Inclusion Criteria:

1. noncardiac surgery in the past 35 days with at least one of the following:

1. an overnight hospital admission after surgery;
2. day surgery resulting in a large enough physiological insult to be able to cause perioperative AF, as judged by the local investigator
2. ≥1 episode of clinically important perioperative AF during or after their surgery;
3. sinus rhythm at the time of randomization; AND
4. any of the following high-risk criteria:

1. age 55-64 years, and having either known cardiovascular disease, recent major vascular surgery, a CHA2DS2VASc score ≥3, or an elevated postoperative troponin level;
2. age 65-74 years, and having either known cardiovascular disease, recent major vascular surgery, a CHA2DS2VASc score ≥2, or an elevated postoperative troponin level; OR
3. age ≥75 years.
5. provide written informed consent

Exclusion Criteria:

1. history of documented chronic AF prior to noncardiac surgery;
2. need for long-term systemic anticoagulation;
3. ongoing need for long-term dual antiplatelet treatment;
4. contraindication to oral anticoagulation;
5. severe renal insufficiency (CrCl \<20 ml/min);
6. severe liver cirrhosis (i.e., Child-Pugh Class C)
7. acute stroke in the past 14 days;
8. underwent cardiac surgery in the past 35 days;
9. history of nontraumatic intracranial, intraocular, or spinal bleeding;
10. hemorrhagic disorder or bleeding diathesis;
11. expected to be non-compliant with follow-up and/or study medications;
12. known life expectancy less than 1 year due to concomitant disease;
13. women who are pregnant, breastfeeding, or of childbearing potential who are not taking effective contraception; OR
14. previously enrolled in the trial

Study Location

University of Alberta Hospital
University of Alberta Hospital
Edmonton, Alberta
Canada

Contact Study Team

Health Sciences Centre Winnipeg
Health Sciences Centre Winnipeg
Winnipeg, Manitoba
Canada

Contact Study Team

Cambridge Cardiac Care Centre
Cambridge Cardiac Care Centre
Cambridge, Ontario
Canada

Contact Study Team

Kingston General Hospital
Kingston General Hospital
Kingston, Ontario
Canada

Contact Study Team

Centre Hospitalier de l'Université de Montréal
Centre Hospitalier de l'Université de Montréal
Montréal, Quebec
Canada

Contact Study Team

Royal University Hospital
Royal University Hospital
Saskatoon, Saskatchewan
Canada

Contact Study Team

Foothills Hospital
Foothills Hospital
Calgary, Alberta
Canada

Contact Study Team

Fraser Health Authority
Fraser Health Authority
Surrey, British Columbia
Canada

Contact Study Team

Cape Breton University
Cape Breton University
Sydney, Nova Scotia
Canada

Contact Study Team

Juravinski Hospital
Juravinski Hospital
Hamilton, Ontario
Canada

Contact Study Team

Niagara Health System - St. Catharine's Site
Niagara Health System - St. Catharine's Site
St. Catharines, Ontario
Canada

Contact Study Team

Regina General Hospital
Regina General Hospital
Regina, Saskatchewan
Canada

Contact Study Team

Medicine Hat Regional Hospital
Medicine Hat Regional Hospital
Medicine Hat, Alberta
Canada

Contact Study Team

Dr.-Georges-L.-Dumont University Hospital Centre
Dr.-Georges-L.-Dumont University Hospital Centre
Moncton, New Brunswick
Canada

Contact Study Team

Hamilton General Hospital
Hamilton General Hospital
Hamilton, Ontario
Canada

Contact Study Team

London Health Sciences Centre - University Hospital
London Health Sciences Centre - University Hospital
London, Ontario
Canada

Contact Study Team

CHU de Quebec Universite Laval
CHU de Quebec Universite Laval
Québec, Quebec
Canada

Contact Study Team

East Kootenay Regional Hospital
East Kootenay Regional Hospital
Cranbrook, British Columbia
Canada

Contact Study Team

Halifax Infirmary
Halifax Infirmary
Halifax, Nova Scotia
Canada

Contact Study Team

St. Joseph's Healthcare Hamilton
St. Joseph's Healthcare Hamilton
Hamilton, Ontario
Canada

Contact Study Team

The Ottawa Hospital General Campus
The Ottawa Hospital General Campus
Ottawa, Ontario
Canada

Contact Study Team

Hôpital Fleurimont du Centre hospitalier universitaire de Sherbrooke
Hôpital Fleurimont du Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec
Canada

Contact Study Team

Study Sponsored By
Population Health Research Institute
Participants Required
More Information
Study ID: NCT03968393